Mereo BioPharma (MREO) Interest & Investment Income (2023 - 2026)
Mereo BioPharma's (MREO) quarterly Interest & Investment Income came in at $327000.0 in Q1 2026, down 50.38% year-on-year from $659000.0 in Q1 2025, and down 22.33% on a QoQ basis from $421000.0 in Q4 2025.
Mereo BioPharma (MREO) Interest & Investment Income (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 4 years of Interest & Investment Income data on file, last reported at $327000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 50.38% year-over-year to $327000.0 in Q1 2026; TTM through Mar 2026 was $1.8 million, a 40.27% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 28.54% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $327000.0, down from $421000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for MREO reached as high as $983000.0 in Q3 2024 and fell as low as $306000.0 in Q1 2023.
- Historically, Interest & Investment Income has averaged $590076.9 across 4 years, with a median of $589000.0 in 2025.
- Across the five-year window, Interest & Investment Income jumped 101.63% in 2024 and plunged 52.21% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $763000.0 in 2023, then rose by 15.47% to $881000.0 in 2024, then plunged by 52.21% to $421000.0 in 2025, then fell by 22.33% to $327000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $327000.0 in Q1 2026, $421000.0 in Q4 2025, and $504000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Mereo BioPharma | 229.80 Mn | 229.80 Mn | - | 327,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 327,000.00 |
| Dec 31, 2025 | 421,000.00 |
| Sep 30, 2025 | 504,000.00 |
| Jun 30, 2025 | 589,000.00 |
| Mar 31, 2025 | 659,000.00 |
| Dec 31, 2024 | 881,000.00 |
| Sep 30, 2024 | 983,000.00 |
| Jun 30, 2024 | 559,000.00 |
| Mar 31, 2024 | 617,000.00 |
| Dec 31, 2023 | 763,000.00 |
| Sep 30, 2023 | 689,000.00 |
| Jun 30, 2023 | 373,000.00 |
| Mar 31, 2023 | 306,000.00 |